We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CAR T cell

News List

Collaboration to develop an automated CAR T-cell manufacturing system for clinics europeanpharmaceuticalreview
June 18, 2021
German oncology clinics are working with Optima Pharma to create an automated manufacturing unit for decentralised production of CAR T-cell therapies in treatment centres.
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer drugs
May 24, 2021
AffyImmune , effective ways to use CAR T cells against solid cancers, announced today that FDA granted Fast Track designation to its lead compound, for the treatment of anaplastic thyroid cancer and refractory poorly differentiated thyroid cancer.
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein firstwordpharma
May 09, 2019
Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers ...
Mustang Bio Establishes CAR T Cell Therapy Mfg. Facility contractpharma
October 31, 2017
Facility in UMass Medicine Science Park will support clinical development and commercialization of CAR T pipeline